Venlo, the Netherlands, February 9, 2021 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced strong results of operations for the fourth quarter and full-year 2020, exceeding the goals for net sales and adjusted earnings per share. Net sales in the fourth quarter of 2020 rose 38% (+36% at constant exchange rates, CER) to... Read more
Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results Feb 08, 2021 4:01 PM EST AUSTIN, Texas, Feb. 8, 2021 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its fourth quarter and full-year ended December 31,... Read more
SAN DIEGO–(BUSINESS WIRE)–Feb. 8, 2021 — Illumina, Inc. (NASDAQ: ILMN) has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, invested in four companies for the second funding cycle... Read more
Thermo Fisher Scientific Analytical Instruments Receive Prominent Industry Awards SAN JOSE, Calif., Feb. 4, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that several of its analytical instruments and solutions have been recognized through multiple respected industry awards. These award-winning analytical solutions support scientists across many sectors including pharmaceuticals,... Read more
FRANKLIN LAKES, N.J., Feb. 4, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $5.315 billion for the first fiscal quarter ended December 31, 2020. This represents an increase of 25.8% over the prior-year period on a reported basis and was primarily driven by the... Read more
4Q Revenue of $1.355 billion; 68% reported growth; 65% organic growth 4Q GAAP EPS from continuing operations of $3.38; Adjusted EPS of $3.96 Initiates First Quarter and Full Year 2021 Guidance WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 2, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for... Read more
Brooks Automation Reports Results of First Quarter of Fiscal 2021, Ended December 31, 2020, and Announces Quarterly Cash Dividend Strong Revenue Growth and Margin Expansion Year Over Year In Both Life Sciences and Semiconductor Solutions CHELMSFORD, Mass., Feb. 2, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the first fiscal quarter... Read more
WALTHAM, Mass., Feb. 1, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2020. Fourth Quarter and Full Year 2020 Highlights Fourth quarter revenue grew 54% to $10.55 billion. Fourth quarter GAAP diluted earnings... Read more
SAN DIEGO–(BUSINESS WIRE)–January 31, 2021—Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China, a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina. The company creation engine... Read more
WASHINGTON, Jan. 28, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2020. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended December 31, 2020, net earnings were $1.2 billion, or $1.66 per diluted common share which represents a... Read more